{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T03:32:12Z","timestamp":1786419132038,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2016\/23\/B\/NZ9\/01012"],"award-info":[{"award-number":["2016\/23\/B\/NZ9\/01012"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Nutr"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Obesity is associated with metabolic dysfunction-associated steatotic liver disease (MASLD), for which drugs and nutraceuticals are being developed. We investigated whether camelina seeds from the\n                      <jats:italic>Brassicaceae<\/jats:italic>\n                      family and their components can attenuate metabolic disorders in animal models of genetic obesity, including fatty liver.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In two separate 5-week experiments, female obese (\n                      <jats:italic>fa<\/jats:italic>\n                      \/\n                      <jats:italic>fa<\/jats:italic>\n                      ) Zucker rats and female\n                      <jats:italic>db<\/jats:italic>\n                      \/\n                      <jats:italic>db<\/jats:italic>\n                      mice were used. By appropriately incorporating camelina seeds or their oil into the diet, we investigated, in the rat model, the effects of the oil and non-oil fractions on intestinal and liver function, as well as on lipid metabolism. Subsequently, in a mouse model, oral administration of glucocamelinin, the main camelina glucosinolate, was performed to determine whether this group of compounds might be responsible for the observed beneficial effects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Dietary camelina seeds counteracted liver hypertrophy and steatosis in obese rats, as confirmed by macroscopic and histological images, along with a several-fold lower content of total fat, triglycerides, and cholesterol (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01 for each). The rat experiment indicated that the non-oil fraction of camelina seeds was responsible for these beneficial effects. Oral glucocamelinin attenuated liver hypertrophy and steatosis in obese mice, as confirmed by macroscopic and histological images, along with considerably lower total fat (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05) and cholesterol (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01) contents. In both obese rats and mice, these and other beneficial effects were associated with alterations in the hepatic expression of genes crucial to lipid and glucose metabolism, including a higher expression of those encoding thyroid hormone receptor\n                      <jats:italic>\u03b2<\/jats:italic>\n                      (THR-\n                      <jats:italic>\u03b2<\/jats:italic>\n                      ;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05) and fibroblast growth factor 21 (FGF21;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      These findings indicate that camelina seeds may be considered both a dietary component and a source of bioactive glucosinolates relevant to MASLD. The mechanism behind the lipid-lowering effect of glucocamelinin may involve hepatic activation of FGF21 signaling through THR-\n                      <jats:italic>\u03b2<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12263-026-00807-x","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T13:54:23Z","timestamp":1780754063000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Camelina seeds and their glucosinolate, glucocamelinin, counteract severe fatty liver in rodents with monogenic obesity"],"prefix":"10.1186","volume":"21","author":[{"given":"Adam","family":"Jurgo\u0144ski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina M.","family":"Opyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Napi\u00f3rkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Fotschki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ucja","family":"Brzuzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"807_CR1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41576-021-00414-z","volume":"23","author":"RJF Loos","year":"2022","unstructured":"Loos RJF, Yeo GSH. The genetics of obesity: from discovery to biology. Nat Rev Genet. 2022;23:120\u201333. https:\/\/doi.org\/10.1038\/s41576-021-00414-z.","journal-title":"Nat Rev Genet"},{"key":"807_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.cgh.2021.02.030","volume":"20","author":"J Liu","year":"2021","unstructured":"Liu J, Ayada I, Zhang X, Wang L, Li Y, Wen T, et al. Estimating global prevalence of metabolic dysfunction associated fatty liver disease in overweight or obese adults. Clin Gastroenterol Hepatol. 2021;20:573\u201382. https:\/\/doi.org\/10.1016\/j.cgh.2021.02.030.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"807_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","volume":"27","author":"VT Samuel","year":"2018","unstructured":"Samuel VT, Shulman GI. Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases. Cell Metab. 2018;27:22\u201341. https:\/\/doi.org\/10.1016\/j.cmet.2017.08.002.","journal-title":"Cell Metab"},{"key":"807_CR4","doi-asserted-by":"publisher","first-page":"105517","DOI":"10.1016\/j.phrs.2021.105517","volume":"166","author":"M Zhao","year":"2021","unstructured":"Zhao M, Chen S, Ji X, Shen X, You J, Liang X, et al. Current innovations in nutraceuticals and functional foods for intervention of non-alcoholic fatty liver disease. Pharmacol Res. 2021;166:105517. https:\/\/doi.org\/10.1016\/j.phrs.2021.105517.","journal-title":"Pharmacol Res"},{"key":"807_CR5","doi-asserted-by":"publisher","first-page":"154925","DOI":"10.1016\/j.metabol.2021.154925","volume":"126","author":"CK Negi","year":"2022","unstructured":"Negi CK, Babica P, Bajard L, Bienertova Vasku J, Tarantino G. Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease. Metabolism. 2022;126:154925. https:\/\/doi.org\/10.1016\/j.metabol.2021.154925.","journal-title":"Metabolism"},{"key":"807_CR6","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3390\/nu10091181","volume":"10","author":"PM Opyd","year":"2018","unstructured":"Opyd PM, Jurgo\u0144ski A, Ju\u015bkiewicz J, Fotschki B, Koza J. Comparative effects of native and defatted flaxseeds on intestinal enzyme activity and lipid metabolism in rats fed a high fat diet containing cholic acid. Nutrients. 2018;10:1181. https:\/\/doi.org\/10.3390\/nu10091181.","journal-title":"Nutrients"},{"key":"807_CR7","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1093\/jn\/nxaa081","volume":"150","author":"PM Opyd","year":"2020","unstructured":"Opyd PM, Jurgo\u0144ski A, Fotschki B, Ju\u015bkiewicz J. Dietary hemp seeds more effectively attenuate disorders in genetically obese rats than their lipid fraction. J Nutr. 2020;150:1425\u201333. https:\/\/doi.org\/10.1093\/jn\/nxaa081.","journal-title":"J Nutr"},{"key":"807_CR8","doi-asserted-by":"publisher","first-page":"20895","DOI":"10.1038\/s41598-021-00397-1","volume":"11","author":"PM Opyd","year":"2021","unstructured":"Opyd PM, Jurgo\u0144ski A. Intestinal, liver and lipid disorders in genetically obese rats are more efficiently reduced by dietary milk thistle seeds than their oil. Sci Rep. 2021;11:20895. https:\/\/doi.org\/10.1038\/s41598-021-00397-1.","journal-title":"Sci Rep"},{"key":"807_CR9","doi-asserted-by":"publisher","first-page":"e14136","DOI":"10.1111\/jfbc.14136","volume":"46","author":"HDJ G\u00f3mez Vel\u00e1zquez","year":"2022","unstructured":"G\u00f3mez Vel\u00e1zquez HDJ, Aparicio Fern\u00e1ndez X, Mora O, Gonz\u00e1lez Davalos ML, de Los R\u00edos EA, Reynoso Camacho R. Chia seeds and chemical elicited sprouts supplementation ameliorates insulin resistance, dyslipidemia, and hepatic steatosis in obese rats. J Food Biochem. 2022;46:e14136. https:\/\/doi.org\/10.1111\/jfbc.14136.","journal-title":"J Food Biochem"},{"key":"807_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.21276\/ap.2016.5.2.2","volume":"5","author":"RN Dharavath","year":"2016","unstructured":"Dharavath RN, Singh S, Chaturvedi S, Luqman S. Camelina sativa (L.) Crantz. A mercantile crop with speckled pharmacological activities. Ann Phytomed. 2016;5:6\u201326. https:\/\/doi.org\/10.21276\/ap.2016.5.2.2.","journal-title":"Ann Phytomed"},{"key":"807_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.31883\/pjfns\/119719","volume":"70","author":"M Karama\u0107","year":"2020","unstructured":"Karama\u0107 M, Gai F, Peiretti PG. Effect of the growth stage of false flax (Camelina sativa L.) on the phenolic compound content and antioxidant potential of the aerial part of the plant. Pol J Food Nutr Sci. 2020;70:189\u201398. https:\/\/doi.org\/10.31883\/pjfns\/119719.","journal-title":"Pol J Food Nutr Sci"},{"key":"807_CR12","doi-asserted-by":"publisher","first-page":"2100035","DOI":"10.1002\/ejlt.202100035","volume":"124","author":"M Mondor","year":"2022","unstructured":"Mondor M, Hern\u00e1ndez \u00c1lvarez AJ. Camelina sativa composition, attributes, and applications: A review. Eur J Lipid Sci Technol. 2022;124:2100035. https:\/\/doi.org\/10.1002\/ejlt.202100035.","journal-title":"Eur J Lipid Sci Technol"},{"key":"807_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.tplants.2010.02.005","volume":"15","author":"IE S\u00f8nderby","year":"2010","unstructured":"S\u00f8nderby IE, Geu Flores F, Halkier BA. Biosynthesis of glucosinolates \u2013 gene discovery and beyond. Trends Plant Sci. 2010;15:283\u201390. https:\/\/doi.org\/10.1016\/j.tplants.2010.02.005.","journal-title":"Trends Plant Sci"},{"key":"807_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.5487\/TR.2014.30.2.109","volume":"30","author":"EJ Choi","year":"2014","unstructured":"Choi EJ, Zhang P, Kwon H. Determination of goitrogenic metabolites in the serum of male wistar rat fed structurally different glucosinolates. Toxicol Res. 2014;30:109\u201316. https:\/\/doi.org\/10.5487\/TR.2014.30.2.109.","journal-title":"Toxicol Res"},{"key":"807_CR15","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3390\/foods14060912","volume":"14","author":"S Baldelli","year":"2025","unstructured":"Baldelli S, Lombardo M, D\u2019Amato A, Karav S, Tripodi G, Aiello G. Glucosinolates in human health: metabolic pathways, bioavailability, and potential in chronic disease prevention. Foods. 2025;14:912. https:\/\/doi.org\/10.3390\/foods14060912.","journal-title":"Foods"},{"key":"807_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2049-1891-5-1","volume":"5","author":"WJ Meadus","year":"2014","unstructured":"Meadus WJ, Duff P, McDonald T, Caine WR. Pigs fed camelina meal increase hepatic gene expression of cytochrome 8b1, aldehyde dehydrogenase, and thiosulfate transferase. J Anim Sci Biotechnol. 2014;5:1. https:\/\/doi.org\/10.1186\/2049-1891-5-1.","journal-title":"J Anim Sci Biotechnol"},{"key":"807_CR17","doi-asserted-by":"publisher","first-page":"1442535","DOI":"10.3389\/fnut.2024.1442535","volume":"11","author":"Q Zhu","year":"2024","unstructured":"Zhu Q, Zhang P, Liu D, Tang L, Yu J, Zhang C, Jiang G. Glucosinolate extract from radish (Raphanus sativus L.) seed attenuates high-fat diet-induced obesity: insights into gut microbiota and fecal metabolites. Front Nutr. 2024;11:1442535. https:\/\/doi.org\/10.3389\/fnut.2024.1442535.","journal-title":"Front Nutr"},{"key":"807_CR18","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.3390\/molecules30132738","volume":"30","author":"RS Babu","year":"2025","unstructured":"Babu RS, Jurgo\u0144ski A. Nutritional and metabolic consequences of camelina seed oil compared to flaxseed oil in a rat diet. Molecules. 2025;30:2738. https:\/\/doi.org\/10.3390\/molecules30132738.","journal-title":"Molecules"},{"key":"807_CR19","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1093\/jn\/127.5.838S","volume":"127","author":"PC Reeves","year":"1997","unstructured":"Reeves PC. Components of the AIN 93 diets as improvements in the AIN 76A diet. J Nutr. 1997;127:838\u201341. https:\/\/doi.org\/10.1093\/jn\/127.5.838S.","journal-title":"J Nutr"},{"key":"807_CR20","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0926-6690(97)00061-7","volume":"7","author":"A Schuster","year":"1998","unstructured":"Schuster A, Friedt W. Glucosinolate content and composition as parameters of quality of Camelina seed. Ind Crop Prod. 1998;7:297\u2013302. https:\/\/doi.org\/10.1016\/S0926-6690(97)00061-7.","journal-title":"Ind Crop Prod"},{"key":"807_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/0003-2697(64)90115-0","volume":"7","author":"A Dahlqvist","year":"1964","unstructured":"Dahlqvist A. Method for assay of intestinal disaccharidases. Anal Biochem. 1964;7:18\u201325. https:\/\/doi.org\/10.1016\/0003-2697(64)90115-0.","journal-title":"Anal Biochem"},{"key":"807_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2754\/avb200170010027","volume":"70","author":"B Hofirek","year":"2001","unstructured":"Hofirek B, Haas D. Comparative studies of ruminal fluid collected by oral tube or by puncture of the caudoventral ruminal sac. Acta Vet Brno. 2001;70:27\u201333. https:\/\/doi.org\/10.2754\/avb200170010027.","journal-title":"Acta Vet Brno"},{"key":"807_CR23","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jff.2017.05.023","volume":"34","author":"R Barczy\u0144ska","year":"2017","unstructured":"Barczy\u0144ska R, Jurgo\u0144ski A, \u015ali\u017cewska K, Ju\u015bkiewicz J, Kapu\u015bniak J. Effects of potato dextrin on the composition and metabolism of the gut microbiota in rats fed standard and high fat diets. J Funct Foods. 2017;34:398\u2013407. https:\/\/doi.org\/10.1016\/j.jff.2017.05.023.","journal-title":"J Funct Foods"},{"key":"807_CR24","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch J, Lees M, Sloane-Stanley-Gibbons SGH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497\u2013509.","journal-title":"J Biol Chem"},{"key":"807_CR25","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot4986","author":"AH Fischer","year":"2008","unstructured":"Fischer AH, Jacobson KA, Rose J, Zeller R. Hematoxylin and eosin staining of tissue and cell sections. CSH Protoc. 2008. https:\/\/doi.org\/10.1101\/pdb.prot4986. pdb.prot4986.","journal-title":"CSH Protoc"},{"key":"807_CR26","doi-asserted-by":"publisher","unstructured":"Wang YW, Sun GD, Sun J, Liu SJ, Wang J, Xu XH, Miao LN. Spontaneous type 2 diabetic rodent models. J Diabetes Res. 2013;401723. https:\/\/doi.org\/10.1155\/2013\/401723.","DOI":"10.1155\/2013\/401723"},{"key":"807_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","volume":"7","author":"DJ Morrison","year":"2016","unstructured":"Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7:189\u2013200. https:\/\/doi.org\/10.1080\/19490976.2015.1134082.","journal-title":"Gut Microbes"},{"key":"807_CR28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1039\/c0fo00080a","volume":"1","author":"P Gunnes","year":"2010","unstructured":"Gunnes P, Gidley MJ. Mechanism underlying the cholesterol lowering properties of soluble dietary fibre polysaccharides. Food Funct. 2010;1:149\u201355. https:\/\/doi.org\/10.1039\/c0fo00080a.","journal-title":"Food Funct"},{"key":"807_CR29","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3109\/00365528809103964","volume":"23","author":"HS Rasmussen","year":"1988","unstructured":"Rasmussen HS, Holtug K, Mortensen PB. Degradation of amino acids to short chain fatty acids in humans. An in vitro study. Scand J Gastroenterol. 1988;23:178\u201382. https:\/\/doi.org\/10.3109\/00365528809103964.","journal-title":"Scand J Gastroenterol"},{"key":"807_CR30","doi-asserted-by":"publisher","unstructured":"Rios-Covian D, Gonz\u00e1lez S, Nogacka AM, Arboleya S, Salazar N, Gueimonde M, Reyes-Gavil\u00e1n CG. de los. An overview on fecal branched short chain fatty acids along human life and as related with body mass index: Associated dietary and anthropometric factors. Front Microbiol. 2020;11:973. https:\/\/doi.org\/10.3389\/fmicb.2020.00973","DOI":"10.3389\/fmicb.2020.00973"},{"key":"807_CR31","doi-asserted-by":"publisher","first-page":"101115","DOI":"10.1016\/j.molmet.2020.101115","volume":"50","author":"DG Mashek","year":"2021","unstructured":"Mashek DG. Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD. Mol Metab. 2021;50:101115. https:\/\/doi.org\/10.1016\/j.molmet.2020.101115.","journal-title":"Mol Metab"},{"key":"807_CR32","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fendo.2018.00382","volume":"9","author":"MA Kowalik","year":"2018","unstructured":"Kowalik MA, Columbano A, Perra A. Thyroid hormones, thyromimetics and their metabolites in the treatment of liver disease. Front Endocrinol. 2018;9:382. https:\/\/doi.org\/10.3389\/fendo.2018.00382.","journal-title":"Front Endocrinol"},{"key":"807_CR33","doi-asserted-by":"publisher","first-page":"981090","DOI":"10.3389\/fendo.2022.981090","volume":"13","author":"S Verma","year":"2022","unstructured":"Verma S, Chakraborti S, Singh OP, Pande V, Dixit R, Pandey AV, Pandey KC. Recognition of fold and function specific sites in the ligand binding domain of the thyroid hormone receptor like family. Front Endocrinol. 2022;13:981090. https:\/\/doi.org\/10.3389\/fendo.2022.981090.","journal-title":"Front Endocrinol"},{"key":"807_CR34","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.3390\/ijms21062061","volume":"21","author":"Y Wang","year":"2020","unstructured":"Wang Y, Nakajima T, Gonzalez FJ, Tanaka N. PPARs as metabolic regulators in the liver: Lessons from liver specific PPAR null mice. Int J Mol Sci. 2020;21:2061. https:\/\/doi.org\/10.3390\/ijms21062061.","journal-title":"Int J Mol Sci"},{"key":"807_CR35","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1210\/en.2003-0973","volume":"145","author":"GJ Grover","year":"2004","unstructured":"Grover GJ, Egan DM, Sleph PG, Beehler BC, Chiellini G, Nguyen NH, Baxter JD, Scanlan TS. Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: Selective actions relative to 3,5,3\u2032-triiodo-L-thyronine. Endocrinology. 2004;145:1656\u201361. https:\/\/doi.org\/10.1210\/en.2003-0973.","journal-title":"Endocrinology"},{"key":"807_CR36","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.atherosclerosis.2013.07.056","volume":"230","author":"R Taub","year":"2013","unstructured":"Taub R, Chiang E, Chabot Blanchet M, Kelly MJ, Reeves RA, Guertin MC, Tardif JC. Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-\u03b2 agonist. Atherosclerosis. 2013;230:373\u201380. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.07.056.","journal-title":"Atherosclerosis"},{"key":"807_CR37","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1476-5381.2011.01597.x","volume":"165","author":"P Balakumar","year":"2012","unstructured":"Balakumar P, Mahadevan N. Interplay between statins and PPARs in improving cardiovascular outcomes: a double-edged sword. Br J Pharmacol. 2012;165:373\u20139. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01597.x.","journal-title":"Br J Pharmacol"},{"key":"807_CR38","doi-asserted-by":"publisher","first-page":"E89","DOI":"10.1152\/ajpendo.00573.2012","volume":"305","author":"DF Vatner","year":"2013","unstructured":"Vatner DF, Weismann D, Beddow SA, Kumashiro N, Erion DM, Liao XH, et al. Thyroid hormone receptor \u03b2 agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways. Am J Physiol Endocrinol Metab. 2013;305:E89\u2013100. https:\/\/doi.org\/10.1152\/ajpendo.00573.2012.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"807_CR39","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1108\/00346651011077036","volume":"40","author":"J Zubr","year":"2010","unstructured":"Zubr J. Carbohydrates, vitamins and minerals of Camelina sativa seed. Nutr Food Sci. 2010;40:523\u201331. https:\/\/doi.org\/10.1108\/00346651011077036.","journal-title":"Nutr Food Sci"},{"key":"807_CR40","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s00424-020-02439-5","volume":"472","author":"H Koepsell","year":"2020","unstructured":"Koepsell H. Glucose transporters in the small intestine in health and disease. Pflugers Arch. 2020;472:1207\u201348. https:\/\/doi.org\/10.1007\/s00424-020-02439-5.","journal-title":"Pflugers Arch"},{"key":"807_CR41","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1093\/jn\/132.4.630","volume":"132","author":"S Wolffram","year":"2002","unstructured":"Wolffram S, Bl\u00f6ck M, Ader P. Quercetin 3-glucoside is transported by the glucose carrier SGLT1 across the brush border membrane of rat small intestine. J Nutr. 2002;132:630\u20135. https:\/\/doi.org\/10.1093\/jn\/132.4.630.","journal-title":"J Nutr"},{"key":"807_CR42","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0006-2952(03)00039-X","volume":"65","author":"AJ Day","year":"2003","unstructured":"Day AJ, Gee JM, DuPont MS, Johnson IT, Williamson G. Absorption of quercetin 3-glucoside and quercetin 4\u2032-glucoside in the rat small intestine: The role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter. Biochem Pharmacol. 2003;65:1199\u2013206. https:\/\/doi.org\/10.1016\/S0006-2952(03)00039-X.","journal-title":"Biochem Pharmacol"},{"key":"807_CR43","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jnutbio.2009.09.010","volume":"21","author":"CC Tai","year":"2010","unstructured":"Tai CC, Ding ST. n-3 polyunsaturated fatty acids regulate lipid metabolism through several inflammation mediators: mechanisms and implications for obesity prevention. J Nutr Biochem. 2010;21:357\u201363. https:\/\/doi.org\/10.1016\/j.jnutbio.2009.09.010.","journal-title":"J Nutr Biochem"},{"key":"807_CR44","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12944-022-01745-4","volume":"21","author":"C Jalili","year":"2022","unstructured":"Jalili C, Talebi S, Mehrabani S, Bagheri R, Wong A, Amirian P, et al. Effects of camelina oil supplementation on lipid profile and glycemic control: a systematic review and dose-response meta-analysis of randomized clinical trials. Lipids Health Dis. 2022;21:132. https:\/\/doi.org\/10.1186\/s12944-022-01745-4.","journal-title":"Lipids Health Dis"},{"key":"807_CR45","doi-asserted-by":"publisher","first-page":"1102862","DOI":"10.3389\/fnut.2023.1102862","volume":"10","author":"Z Kavyani","year":"2023","unstructured":"Kavyani Z, Dehghan P, Khani M, Khalafi M, Rosenkranz SK. The effects of Camelina sativa oil and high-intensity interval training on liver function and metabolic outcomes in male type 2 diabetic rats. Front Nutr. 2023;10:1102862. https:\/\/doi.org\/10.3389\/fnut.2023.1102862.","journal-title":"Front Nutr"},{"key":"807_CR46","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.2903\/j.efsa.2016.4593","volume":"14","author":"HK Knutsen","year":"2016","unstructured":"Knutsen HK, Alexander J, Barregard L, et al. Scientific opinion on erucic acid in feed and food. EFSA J. 2016;14:4593. https:\/\/doi.org\/10.2903\/j.efsa.2016.4593.","journal-title":"EFSA J"},{"key":"807_CR47","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1039\/b400004k","volume":"21","author":"B Holst","year":"2004","unstructured":"Holst B, Williamson G. A critical review of the bioavailability of glucosinolates and related compounds. Nat Prod Rep. 2004;21:425\u201347. https:\/\/doi.org\/10.1039\/b400004k.","journal-title":"Nat Prod Rep"},{"key":"807_CR48","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1439-0396.2007.00752.x","volume":"92","author":"P Nguyen","year":"2008","unstructured":"Nguyen P, Leray V, Diez M, Serisier S, Le Bloc\u2019h J, Siliart B, Dumon H. Liver lipid metabolism. J Anim Physiol Anim Nutr. 2008;92:272\u201383. https:\/\/doi.org\/10.1111\/j.1439-0396.2007.00752.x.","journal-title":"J Anim Physiol Anim Nutr"},{"key":"807_CR49","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jhep.2022.02.006","volume":"77","author":"E Bugianesi","year":"2022","unstructured":"Bugianesi E, Petta S, NAFLD\/NASH. J Hepatol. 2022;77:549\u201350. https:\/\/doi.org\/10.1016\/j.jhep.2022.02.006.","journal-title":"J Hepatol"},{"key":"807_CR50","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/17512433.2021.1884068","volume":"14","author":"M Rau","year":"2021","unstructured":"Rau M, Geier A. An update on drug development for the treatment of nonalcoholic fatty liver disease \u2013 from ongoing clinical trials to future therapy. Exp Rev Clin Pharmacol. 2021;14:333\u201340. https:\/\/doi.org\/10.1080\/17512433.2021.1884068","journal-title":"Exp Rev Clin Pharmacol"},{"key":"807_CR51","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","volume":"71","author":"M Trauner","year":"2022","unstructured":"Trauner M, Fuchs CD. Novel therapeutic targets for cholestatic and fatty liver disease. Gut. 2022;71:194\u2013209. https:\/\/doi.org\/10.1136\/gutjnl-2021-324305.","journal-title":"Gut"},{"key":"807_CR52","doi-asserted-by":"publisher","first-page":"14078","DOI":"10.1074\/jbc.C110.107375","volume":"285","author":"AC Adams","year":"2010","unstructured":"Adams AC, Astapova I, Fisher FN, Badman MK, Kurgansky KE, Flier JS, Hollenberg AN, Maratos-Flier E. Thyroid hormone regulates hepatic expression of fibroblast growth factor 21 in a PPAR\u03b1-dependent manner. J Biol Chem. 2010;285:14078\u201382. https:\/\/doi.org\/10.1074\/jbc.C110.107375.","journal-title":"J Biol Chem"}],"container-title":["Genes &amp; Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12263-026-00807-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12263-026-00807-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12263-026-00807-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T03:25:18Z","timestamp":1786418718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12263-026-00807-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["807"],"URL":"https:\/\/doi.org\/10.1186\/s12263-026-00807-x","relation":{},"ISSN":["1555-8932","1865-3499"],"issn-type":[{"value":"1555-8932","type":"print"},{"value":"1865-3499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Both experiment protocols were in accordance with European Union legislations for the care and use of laboratory animals (Directive 2010\/63\/EU) and ARRIVE guidelines, and were approved by the Local Institutional Animal Care and Use Committee in Olsztyn, Poland (permission numbers: 37\/2017 and 75\/2022 for rats and mice, respectively).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"19"}}